Intravenous Pertussis Immune Globulin in Patients With Severe Childhood Pertussis Infection

IWK Health Centre174 enrolled

Overview

OBJECTIVES: Assess the efficacy of a single infusion of a high titer pertussis immune globulin for the treatment of severe pertussis in children.

PROTOCOL OUTLINE: This is a randomized, multicenter study. Patients are randomized to receive an infusion of either pertussis immune globulin or placebo (0.9% saline). Patients are followed every 2 weeks for up to 6 months. Completion date provided represents the completion date of the grant per OOPD records

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Enrollment

174

Conditions

Pertussis Whooping Cough

Interventions

immune globulinDRUG

Eligibility

Sex: ALLMax age: 5 Years

Medical Language ↔ Plain English

* Documented infection with Bordetella pertussis

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.